Entries by Maren Kühr

CRISPR & Co.: Brave new food

The possibilities offered by CRISPR/Cas9, TALENs and other new genome editing technologies are making the mouths of plant breeders water – and not just because the methods give seed developers new options when it comes to optimising traits such as yield, resistance to environmental stress, diseases or pests. Gene-edited plants could soon make inroads even with Europe’s strict regulators, and throw open the door to tastier, healthier food.

Cleaning up the oceans

French green chemistry pioneer, Carbios SA (Clermont-Ferrand) announced in March that it has secured equity financing of €2.5m from Kepler Cheuvreux through the acquisition of 380,000 shares over 24 months. 

LowCross-Buffer

Antibody and sample diluent for minimizing nonspecific binding, cross-reactivities and matrix effects in immunoassays.

The SIDUS® technology platform

Originates from the in-depth experience and complete protocol system concerning the manufacture of viral vectors for vaccines or gene therapy.

TxCell gains Treg rights

French immunotherapy company TxCell has teamed up with Inserm Transfert, the tech transfer subsidiary of the French National Institute of Health and Medical Research Inserm, to develop immuno-suppressive regulatory T cells.

A fresh take on biotech?

For the second time, biotech communication start-up Labiotech hosted its event LBRefresh, this year in Paris, France. Participants enjoyed panel discussions, a start-up battle and intimate fireside chats…